Needham & Company on Watson Pharmaceuticals (WPI): Deal With Amgen Couples WPI’s Checkbook With Biotech Icon’s Development Prowess
Go back to Needham & Company on Watson Pharmaceuticals (WPI): Deal With Amgen Couples WPI’s Checkbook With Biotech Icon’s Development Prowess| Amgen Inc (NASDAQ: AMGN) | Delayed: 415.21 -2.63 (0.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $417.84 | 52 Week High | $176.85 | |||
| Open | $413.76 | 52 Week Low | $133.64 | |||
| Day High | $416.03 | P/E | 62.53 | |||
| Day Low | $410.50 | EPS | $6.64 | |||
| Volume | 2,036,286 | |||||
| Watson Pharmaceuticals, Inc. (NYSE: WPI) | Delayed: 85.73 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $85.73 | 52 Week High | $91.47 | |||
| Open | $16.30 | 52 Week Low | $57.16 | |||
| Day High | $85.73 | P/E | 66.46 | |||
| Day Low | $85.73 | EPS | $1.29 | |||
| Volume | 3,625 | |||||
